Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Will Dampier

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Scientific Reports|November 2, 2017
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variantsWill Dampier, Neil T Sullivan, Cheng-Han Chung, et al.
Expert Opinion on Biological Therapy|December 17, 2020
HIV-1 cure strategies: why CRISPR?Andrew J Atkins, Alexander G Allen, Will Dampier, et al.
Frontiers in Microbiology|May 30, 2024
Delivering CRISPR to the HIV-1 reservoirsTheodore E Gurrola, Samuel N Effah, Ilker K Sariyer, et al.
Frontiers in Microbiology|January 9, 2019
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus InfectionAlexander G Allen, Cheng-Han Chung, Andrew Atkins, et al.
Current HIV Research|May 28, 2014
Bioinformatic analysis of HIV-1 entry and pathogenesisBenjamas Aiamkitsumrit, Will Dampier, Gregory Antell, et al.
Microbiology Resource Announcements|May 2, 2020
Integrated Human Immunodeficiency Virus Type 1 Sequence in J-Lat 10.6Cheng-Han Chung, Anthony R Mele, Alexander G Allen, et al.
Frontiers in Cellular and Infection Microbiology|March 26, 2021
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral TherapyCheng-Han Chung, Alexander G Allen, Andrew Atkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 2, 2019
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage EfficiencyCheng-Han Chung, Alexander G Allen, Neil T Sullivan, et al.
Frontiers in Microbiology|September 9, 2020
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target EditingNeil T Sullivan, Alexander G Allen, Andrew J Atkins, et al.
Frontiers in Genome Editing|October 29, 2021
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 TherapyAndrew Atkins, Cheng-Han Chung, Alexander G Allen, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 2, 2017
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variantsWill Dampier, Neil T Sullivan, Cheng-Han Chung, et al.
Expert Opinion on Biological Therapy|December 17, 2020
HIV-1 cure strategies: why CRISPR?Andrew J Atkins, Alexander G Allen, Will Dampier, et al.
Frontiers in Microbiology|May 30, 2024
Delivering CRISPR to the HIV-1 reservoirsTheodore E Gurrola, Samuel N Effah, Ilker K Sariyer, et al.
Frontiers in Microbiology|January 9, 2019
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus InfectionAlexander G Allen, Cheng-Han Chung, Andrew Atkins, et al.
Current HIV Research|May 28, 2014
Bioinformatic analysis of HIV-1 entry and pathogenesisBenjamas Aiamkitsumrit, Will Dampier, Gregory Antell, et al.
Microbiology Resource Announcements|May 2, 2020
Integrated Human Immunodeficiency Virus Type 1 Sequence in J-Lat 10.6Cheng-Han Chung, Anthony R Mele, Alexander G Allen, et al.
Frontiers in Cellular and Infection Microbiology|March 26, 2021
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral TherapyCheng-Han Chung, Alexander G Allen, Andrew Atkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 2, 2019
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage EfficiencyCheng-Han Chung, Alexander G Allen, Neil T Sullivan, et al.
Frontiers in Microbiology|September 9, 2020
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target EditingNeil T Sullivan, Alexander G Allen, Andrew J Atkins, et al.
Frontiers in Genome Editing|October 29, 2021
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 TherapyAndrew Atkins, Cheng-Han Chung, Alexander G Allen, et al.
Pageof 5